LabTurbo Biotech (ROCO:7725) Net Margin %: -108.13% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
14 GF Score
Price NT$23.00
! 2 Warning Signs
View Full Analysis

What is LabTurbo Biotech Net Margin %?

LabTurbo Biotech ROCO:7725 14 Net Margin % is -108.13% as of Dec. 2025. GuruFocus rates ROCO:7725 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 941 Biotechnology companies, LabTurbo Biotech ranks worse than 57.81% on this metric.

Net margin is calculated as Net Income divided by its Revenue. LabTurbo Biotech's Net Income for the six months ended in Dec. 2025 was NT$-45.64 Mil. LabTurbo Biotech's Revenue for the six months ended in Dec. 2025 was NT$42.21 Mil. Therefore, LabTurbo Biotech's net margin for the quarter that ended in Dec. 2025 was -108.13%.

The historical rank and industry rank for LabTurbo Biotech's Net Margin % or its related term are showing as below:

ROCO:7725' s Net Margin % Range Over the Past 10 Years
Min: -166.36   Med: 17.76   Max: 47.89
Current: -166.36

ROCO:7725's Net Margin % is ranked worse than
57.81% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:7725: -166.36

LabTurbo Biotech  (ROCO:7725) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

LabTurbo Biotech Net Margin % Related Terms

LabTurbo Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech Net Margin % Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
46.81 47.89 -34.21 17.76 -166.36

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only -148.79 207.83 -226.88 -233.02 -108.13

ROCO:7725 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, LabTurbo Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LabTurbo Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LabTurbo Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where LabTurbo Biotech's Net Margin % falls into.


ROCO:7725
14GF Score
LabTurbo Biotech Corp ROCO:7725
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

LabTurbo Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-131.538/79.07
=-166.36 %

LabTurbo Biotech's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-45.635/42.205
=-108.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -108.13% mean?
LabTurbo Biotech (ROCO:7725) has a Net Margin % of -108.13% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on LabTurbo Biotech and its competitors. According to the industry distribution chart, LabTurbo Biotech ranks #544 out of 941 companies in the Biotechnology industry, placing it in the top 57.8%.
Is LabTurbo Biotech's Net Margin % too high?
LabTurbo Biotech's current Net Margin % is -108.13%. Based on the distribution chart, LabTurbo Biotech ranks #544 out of 941 companies in the Biotechnology industry, which is below the industry midpoint. Overall, LabTurbo Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LabTurbo Biotech ranks #544 out of 941 companies for Net Margin %. This places LabTurbo Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on LabTurbo Biotech and its competitors. LabTurbo Biotech's current Net Margin % is -108.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
LabTurbo Biotech (ROCO:7725) has a current Net Margin % of -108.13%. The current Net Margin % is -108.13%. LabTurbo Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current Net Margin % is -108.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
14GF Score

Get the complete analysis for ROCO:7725

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.00
Price